JP2008526989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526989A5 JP2008526989A5 JP2007551410A JP2007551410A JP2008526989A5 JP 2008526989 A5 JP2008526989 A5 JP 2008526989A5 JP 2007551410 A JP2007551410 A JP 2007551410A JP 2007551410 A JP2007551410 A JP 2007551410A JP 2008526989 A5 JP2008526989 A5 JP 2008526989A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- disease
- compound according
- unsubstituted
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64379605P | 2005-01-13 | 2005-01-13 | |
| US60/643,796 | 2005-01-13 | ||
| US70998005P | 2005-08-19 | 2005-08-19 | |
| US60/709,980 | 2005-08-19 | ||
| PCT/US2006/001275 WO2006076595A1 (en) | 2005-01-13 | 2006-01-13 | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013151233A Division JP5841569B2 (ja) | 2005-01-13 | 2013-07-22 | ハロアリール置換アミノプリン、その組成物、およびそれによる治療の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008526989A JP2008526989A (ja) | 2008-07-24 |
| JP2008526989A5 true JP2008526989A5 (cg-RX-API-DMAC7.html) | 2009-02-26 |
| JP5475949B2 JP5475949B2 (ja) | 2014-04-16 |
Family
ID=36228639
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007551410A Expired - Lifetime JP5475949B2 (ja) | 2005-01-13 | 2006-01-13 | ハロアリール置換アミノプリン、その組成物、およびそれによる治療の方法 |
| JP2013151233A Expired - Lifetime JP5841569B2 (ja) | 2005-01-13 | 2013-07-22 | ハロアリール置換アミノプリン、その組成物、およびそれによる治療の方法 |
| JP2015187617A Pending JP2016065057A (ja) | 2005-01-13 | 2015-09-25 | ハロアリール置換アミノプリン、その組成物、およびそれによる治療の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013151233A Expired - Lifetime JP5841569B2 (ja) | 2005-01-13 | 2013-07-22 | ハロアリール置換アミノプリン、その組成物、およびそれによる治療の方法 |
| JP2015187617A Pending JP2016065057A (ja) | 2005-01-13 | 2015-09-25 | ハロアリール置換アミノプリン、その組成物、およびそれによる治療の方法 |
Country Status (22)
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7256196B1 (en) * | 2003-12-09 | 2007-08-14 | The Procter & Gamble Company | Purine cytokine inhibitors |
| US7759342B2 (en) | 2005-01-13 | 2010-07-20 | Signal Pharmaceuticals, Llc | Methods of treatment and prevention using haloaryl substituted aminopurines |
| US7521446B2 (en) * | 2005-01-13 | 2009-04-21 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| US7723340B2 (en) * | 2005-01-13 | 2010-05-25 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| GB0526042D0 (en) * | 2005-12-21 | 2006-02-01 | Syngenta Participations Ag | Chemical compounds |
| BRPI0707719A2 (pt) | 2006-02-10 | 2011-05-10 | Summit Corp Plc | uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo |
| TWI398252B (zh) * | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| AU2007309167A1 (en) * | 2006-10-20 | 2008-05-02 | N.V. Organon | Purines as PKC-theta inhibitors |
| NZ576347A (en) * | 2006-10-27 | 2011-10-28 | Signal Pharm Llc | Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
| AU2008285289A1 (en) | 2007-08-03 | 2009-02-12 | Biomarin Iga Limited | Drug combinations for the treatment of Duchenne muscular dystrophy |
| GB0715937D0 (en) * | 2007-08-15 | 2007-09-26 | Vastox Plc | Method of treatment og duchenne muscular dystrophy |
| CL2009000904A1 (es) | 2008-04-21 | 2010-04-30 | Shionogi & Co | Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende. |
| AU2009284098B2 (en) | 2008-08-22 | 2012-03-29 | Astex Therapeutics Ltd. | Pyrrolopyrimidine compounds as CDK inhibitors |
| UY32138A (es) * | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables |
| UY32470A (es) | 2009-03-05 | 2010-10-29 | Boehringer Ingelheim Int | Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones |
| WO2011071491A1 (en) * | 2009-12-09 | 2011-06-16 | Signal Pharmaceuticals, Llc | Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2, 4, 6- trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| EP2338888A1 (en) | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
| US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
| US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
| UY33227A (es) | 2010-02-19 | 2011-09-30 | Novartis Ag | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 |
| US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
| CN102260263A (zh) * | 2010-05-26 | 2011-11-30 | 四川大学 | 一类二苯胺基嘌呤衍生物及制备方法和医药用途 |
| US8759537B2 (en) | 2010-08-20 | 2014-06-24 | Boehringer Ingelheim International Gmbh | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents |
| US8586604B2 (en) | 2010-08-20 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
| US8603527B2 (en) | 2010-10-25 | 2013-12-10 | Signal Pharmaceuticals, Llc | Pharmaceutical formulations of a substituted diaminopurine |
| US8680076B2 (en) | 2010-10-25 | 2014-03-25 | Signal Pharmaceuticals, Llc | Methods of treatment, improvement and prevention using haloaryl substituted aminopurines |
| TWI410425B (zh) | 2010-12-03 | 2013-10-01 | Lilly Co Eli | 唑并[5,4-b]吡啶-5-基化合物 |
| US8466186B2 (en) | 2010-12-10 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Compounds |
| US8486968B2 (en) | 2010-12-10 | 2013-07-16 | Boehringer Ingelheim International Gmbh | Compounds |
| UY33779A (es) | 2010-12-10 | 2012-07-31 | Boehringer Ingelheim Int | ?2-(fenilamino)-1H-bencimidazol-5-carboxamidas novedosas? |
| DK2734205T3 (en) | 2011-07-21 | 2018-06-14 | Tolero Pharmaceuticals Inc | Heterocyclic Protein Kinase Inhibitors |
| US9493464B2 (en) | 2012-02-29 | 2016-11-15 | The Scripps Research Institute | Wee1 degradation inhibitors |
| EP2964648B1 (en) | 2013-03-05 | 2016-11-16 | Merck Patent GmbH | 9-(aryl or heteroaryl)-2-(pyrazolyl, pyrrolidinyl or cyclopentyl)aminopurine derivatives as anticancer agents |
| CN104098563A (zh) * | 2013-04-02 | 2014-10-15 | 山东亨利医药科技有限责任公司 | Jnk抑制剂化合物 |
| EP2994471B1 (en) | 2013-05-06 | 2017-05-17 | Merck Patent GmbH | Macrocycles as kinase inhibitors |
| EP4772247A2 (en) | 2013-08-14 | 2026-07-08 | Novartis AG | Combination therapy comprising ribociclib and fulvestrant for the treatment of cancer |
| DK3204386T3 (da) * | 2014-10-06 | 2021-05-25 | Signal Pharm Llc | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed |
| US10576085B2 (en) * | 2016-04-01 | 2020-03-03 | Signal Pharmaceuticals, Llc | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith |
| MX379439B (es) | 2016-04-01 | 2025-03-10 | Signal Pharm Llc | Formas sólidas de (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahidro-2h-piran-4-il)amino)-8-((2,4,6-triclorofenil)amino)-9h-purin-9-il)-1-metilciclohexano-1-carboxamida y métodos para utilizarlas. |
| ES2926149T3 (es) * | 2016-06-02 | 2022-10-24 | Celgene Corp | Agentes antipalúdicos animales y humanos |
| US10010555B2 (en) | 2016-06-02 | 2018-07-03 | Celgene Corporation | Animal and human anti-trypanosomonal and anti-leishmania agents |
| WO2018029336A1 (en) | 2016-08-12 | 2018-02-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for determining whether a subject was administered with an activator of the ppar beta/delta pathway. |
| EP4086257A1 (en) * | 2016-09-30 | 2022-11-09 | SRI International | Dual clk/cdk1 inhibitors for cancer treatment |
| CN106632339B (zh) * | 2016-12-16 | 2018-11-27 | 温州医科大学 | 一种6-取代-9h-嘌呤类衍生物及其制备方法和应用 |
| EP3692041A1 (en) | 2017-10-04 | 2020-08-12 | Celgene Corporation | Processes for the preparation of cis-4 [2-{(3s.4r)-3-fluorooxan-4-yl]amino)-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1-methylcyclohexane-1-carboxamide |
| MX2020003620A (es) | 2017-10-04 | 2020-10-28 | Celgene Corp | Composiciones y métodos para usar cis-4-[2-{[(3s,4r)-3-fluorooxan- 4-il]amino}-8-(2,4,6-tricloroanilino)-9h-purin-9-il]-1-etilcicloh exano-1-carboxamida. |
| CN109694395B (zh) * | 2017-10-23 | 2020-08-28 | 武汉惠康达科技有限公司 | 一种用于缺血再灌注损伤的化合物及其制备方法 |
| CN107892691B (zh) * | 2017-12-19 | 2020-04-28 | 西安交通大学 | 2,8,9-三取代-9h-嘌呤类化合物及其盐和应用 |
| WO2020007698A1 (en) * | 2018-07-06 | 2020-01-09 | Leo Pharma A/S | Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
| HUE072069T2 (hu) | 2019-02-12 | 2025-10-28 | Sumitomo Pharma America Inc | 2-((1R,4R)-4-((3-(3-(trifluormetil)fenil)imidazo[1,2- b]piridazin-6-il)amino)ciklohexil)propán-2-ol sósavas sójának kristályos formája |
| US20230099367A1 (en) * | 2019-04-16 | 2023-03-30 | Versitech Limited | Purmorphamine as a small compound positive allosteric modulator of secretin receptor for the treatment of hypertension |
| EP3772513A1 (en) * | 2019-08-09 | 2021-02-10 | C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening | Shp2 inhibitors |
| CN112430632B (zh) * | 2020-11-18 | 2022-09-13 | 上海合全药物研发有限公司 | 2-((反式)-4-氨基环己烷基)异丙醇的制备方法 |
| CN113582995B (zh) * | 2021-08-17 | 2022-08-16 | 西安交通大学 | 9-位含有丙烯酰氨基片段的-9h-嘌呤类化合物及其盐和应用 |
| TW202329937A (zh) | 2021-12-03 | 2023-08-01 | 美商英塞特公司 | 雙環胺ck12抑制劑 |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| WO2023133354A2 (en) * | 2022-01-10 | 2023-07-13 | Southern Research Institute | Development of potential antidotes for arsenicals |
| CN117430614B (zh) * | 2023-12-20 | 2024-03-08 | 首都医科大学 | 一种异喹啉类衍生物及其合成方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US643796A (en) | 1899-08-03 | 1900-02-20 | William H Hunter | Washing-machine. |
| US709980A (en) | 1901-02-04 | 1902-09-30 | Hubert Gilljam | Carding-machine. |
| IL78643A0 (en) * | 1985-05-02 | 1986-08-31 | Wellcome Found | Purine derivatives,their preparation and pharmaceutical compositions containing them |
| US5332744A (en) | 1989-05-30 | 1994-07-26 | Merck & Co., Inc. | Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists |
| WO1999007705A1 (en) | 1997-08-07 | 1999-02-18 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
| CZ27399A3 (cs) | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
| TR200601782T2 (tr) | 1999-11-12 | 2006-09-21 | Pharmasset Ltd. | 2'-Deoksi-L-Nükleositlerin sentezi. |
| US20030187261A1 (en) | 2000-01-07 | 2003-10-02 | Libor Havlicek | Purine derivatives, process for their preparation and use thereof |
| WO2002020495A2 (en) | 2000-09-06 | 2002-03-14 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| BRPI0113757B8 (pt) | 2000-09-11 | 2017-11-07 | Chiron Corp | derivados de quinolinona como inibidores de tirosina quinase |
| JP2005504727A (ja) | 2001-04-13 | 2005-02-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症薬として有用なウレア化合物 |
| WO2003030909A1 (en) | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| US7256196B1 (en) | 2003-12-09 | 2007-08-14 | The Procter & Gamble Company | Purine cytokine inhibitors |
| BRPI0517272A (pt) | 2004-10-29 | 2008-10-07 | Tibotec Pharm Ltd | derivados de pirimidina bicìclicos de inibição de hiv |
| US7521446B2 (en) * | 2005-01-13 | 2009-04-21 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| US7759342B2 (en) * | 2005-01-13 | 2010-07-20 | Signal Pharmaceuticals, Llc | Methods of treatment and prevention using haloaryl substituted aminopurines |
| US7723340B2 (en) * | 2005-01-13 | 2010-05-25 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| NZ576347A (en) * | 2006-10-27 | 2011-10-28 | Signal Pharm Llc | Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
-
2006
- 2006-01-12 US US11/332,617 patent/US7723340B2/en active Active
- 2006-01-13 WO PCT/US2006/001275 patent/WO2006076595A1/en not_active Ceased
- 2006-01-13 EP EP10182984.4A patent/EP2289893B1/en not_active Expired - Lifetime
- 2006-01-13 PT PT06718361T patent/PT1838710E/pt unknown
- 2006-01-13 KR KR1020077018501A patent/KR101294830B1/ko not_active Expired - Fee Related
- 2006-01-13 CA CA2595182A patent/CA2595182C/en not_active Expired - Lifetime
- 2006-01-13 ES ES10182984.4T patent/ES2497540T3/es not_active Expired - Lifetime
- 2006-01-13 RS RSP-2009/0402A patent/RS51176B/sr unknown
- 2006-01-13 MX MX2007008485A patent/MX2007008485A/es active IP Right Grant
- 2006-01-13 PL PL06718361T patent/PL1838710T3/pl unknown
- 2006-01-13 CN CN201210551660XA patent/CN103087066A/zh active Pending
- 2006-01-13 EP EP09008136.5A patent/EP2112151B1/en not_active Expired - Lifetime
- 2006-01-13 DE DE602006007541T patent/DE602006007541D1/de not_active Expired - Lifetime
- 2006-01-13 NZ NZ556654A patent/NZ556654A/en unknown
- 2006-01-13 HR HR20090383T patent/HRP20090383T1/xx unknown
- 2006-01-13 AT AT06718361T patent/ATE435227T1/de active
- 2006-01-13 SI SI200630365T patent/SI1838710T1/sl unknown
- 2006-01-13 AU AU2006204792A patent/AU2006204792B2/en not_active Expired
- 2006-01-13 EP EP06718361A patent/EP1838710B1/en not_active Expired - Lifetime
- 2006-01-13 ES ES09008136.5T patent/ES2448500T3/es not_active Expired - Lifetime
- 2006-01-13 BR BRPI0606702-6A patent/BRPI0606702A2/pt not_active IP Right Cessation
- 2006-01-13 JP JP2007551410A patent/JP5475949B2/ja not_active Expired - Lifetime
- 2006-01-13 DK DK06718361T patent/DK1838710T3/da active
- 2006-01-13 ES ES06718361T patent/ES2326388T3/es not_active Expired - Lifetime
-
2007
- 2007-07-12 IL IL184550A patent/IL184550A/en not_active IP Right Cessation
-
2009
- 2009-08-12 US US12/540,013 patent/US20090312320A1/en not_active Abandoned
- 2009-08-12 CY CY20091100859T patent/CY1109306T1/el unknown
-
2013
- 2013-07-22 JP JP2013151233A patent/JP5841569B2/ja not_active Expired - Lifetime
- 2013-12-05 IL IL229831A patent/IL229831A/en active IP Right Grant
-
2015
- 2015-09-25 JP JP2015187617A patent/JP2016065057A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2595182A1 (en) | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith | |
| ES2638517T3 (es) | Derivados de arilmetoxi isoindolina y composiciones que los comprenden y métodos de uso de los mismos | |
| CN104487441B (zh) | 有用于治疗癌症和自身免疫性疾病的可逆的共价吡咯并嘧啶或吡唑并嘧啶 | |
| RU98123097A (ru) | Карбоксамиды бензофурана и их терапевтическое применение | |
| TWI699359B (zh) | 4h-吡咯[3,2-c]吡啶-4-酮衍生物 | |
| ES2878030T3 (es) | Inhibidores de tirosina cinasa | |
| CN1285833A (zh) | 嘌呤衍生物以及含有其作为有效成分的药物 | |
| CN100595199C (zh) | 改变药物晶体形成的方法 | |
| ES2539256T3 (es) | Compuestos de 3-fenil-1,2,4-oxadiazol sustituidos | |
| JP2024513494A5 (cg-RX-API-DMAC7.html) | ||
| JP2009534421A5 (cg-RX-API-DMAC7.html) | ||
| JP2021523159A5 (cg-RX-API-DMAC7.html) | ||
| CN1152870A (zh) | 杂环化合物作为多巴胺d3配位体的用途 | |
| CA2537127A1 (en) | Benzimidazolone compounds having 5-ht4 receptor agonistic activity | |
| JP2009524691A5 (cg-RX-API-DMAC7.html) | ||
| JP2002516314A5 (cg-RX-API-DMAC7.html) | ||
| RS56807B1 (sr) | Jedinjenja aminopirimidinila kao jak inhibitori | |
| CA2952307A1 (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
| CA2545092A1 (en) | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity | |
| JP2005539045A5 (cg-RX-API-DMAC7.html) | ||
| JP2015532289A5 (cg-RX-API-DMAC7.html) | ||
| EA018995B1 (ru) | Производные карбаматов алкилтиазолов, их получение и их применение в терапии | |
| JP2016028076A5 (cg-RX-API-DMAC7.html) | ||
| RU2006120486A (ru) | Гидроксиалкилзамещенные пиридо-7-пиримидин-7-оны | |
| KR20200011388A (ko) | Jnk 저해 활성을 갖는 신규한 이미다졸 유도체 및 이를 포함하는 약학적 조성물 |